Low CPNE3 Expression is Associated with Risk of Acute Myocardial Infarction: A Feasible Genetic Marker of Acute Myocardial Infarction in Patients with Stable Coronary Artery Disease

Overview

Journal Cardiol J

Specialty Cardiology & Vascular Diseases

Date 2018 Jan 4

PMID 29297177

Citations 15

Authors

Buchuan Tan

Long Liu

Yushuang Yang

Qian Liu

Liping Yang

Fanbo Meng

Affiliations

Soon will be listed here.

Abstract

Background: Gene COPINE III may be related to a phosphoprotein with intrinsic kinase activity and belongs to an unconventional kinase family. The CPNE3 gene may be used as a biomarker for assess- ment of occurrence and prognosis of various tumors.

Methods: Peripheral blood was collected from 87 stable coronary artery disease (CAD) patients and 91 acute myocardial infarction (AMI) patients. Real-time quantitative polymerase chain reaction test and the western blot method were adopted to measure expression quantity of CPNE3 gene at the mRNA level and the protein level.

Results: The expression of the CPNE3 gene in peripheral blood of AMI patients was significantly lower than those in peripheral blood of stable CAD patients. Low expression of CPNE3 gene was found to be unrelated to level of fasting blood glucose and serum blood lipid of patients, quantity of cardiac troponin and time of onset but was found to be correlated to the Gensini score for coronary artery. When the ex- pression of CPNE3 gene at the mRNA level in peripheral blood was used as the criterion for diagnosing AMI, its sensitivity, specificity, positive predictive value and negative predictive value were 69%, 64.8%, 68.6% and 65.2%, respectively.

Conclusions: Compared to stable CAD patients, AMI patients have a lower expression of CPNE3 gene in their peripheral blood. Patients who have low CPNE3 expression in peripheral blood are more likely to suffer from AMI than those with stable CAD. Low expression of CPNE3 gene serves as an potential independent risk factor of AMI.

Citing Articles

YAP1-CPNE3 positive feedback pathway promotes gastric cancer cell progression.

Li X, Zhong H, Shi Q, Ruan R, Huang C, Wen Q Cell Mol Life Sci. 2024; 81(1):143.

PMID: 38493426 PMC: 10944813. DOI: 10.1007/s00018-024-05178-3.

Copine7 deficiency leads to hepatic fat accumulation via mitochondrial dysfunction.

Hwang G, Seo H, Park J Heliyon. 2023; 9(11):e21676.

PMID: 37954344 PMC: 10637907. DOI: 10.1016/j.heliyon.2023.e21676.

Role of serum CAP1 protein in the diagnosis of patients with first-time acute myocardial infarction.

Jin D, Li X, Cong H, You B, Ma Y, Hu Y Medicine (Baltimore). 2023; 102(39):e34700.

PMID: 37773847 PMC: 10545083. DOI: 10.1097/MD.0000000000034700.

New Progress in Early Diagnosis of Atherosclerosis.

Meng H, Ruan J, Yan Z, Chen Y, Liu J, Li X Int J Mol Sci. 2022; 23(16).

PMID: 36012202 PMC: 9409135. DOI: 10.3390/ijms23168939.

Expression of Membrane Bound O-Acyltransferase Domain Containing 7 after Myocardial Infarction and its Role in Lipid Metabolism .

Li X, Wang Z, Meng H, Meng F, Yang P Int J Med Sci. 2022; 19(4):609-617.

PMID: 35582424 PMC: 9108405. DOI: 10.7150/ijms.70614.

References

Libby P, Theroux P . Pathophysiology of coronary artery disease. Circulation. 2005; 111(25):3481-8. DOI: 10.1161/CIRCULATIONAHA.105.537878. View

Jacobson T, Ito M, Maki K, Orringer C, Bays H, Jones P . National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary. J Clin Lipidol. 2014; 8(5):473-88. DOI: 10.1016/j.jacl.2014.07.007. View

Otaki Y, Gransar H, Berman D, Cheng V, Dey D, Lin F . Impact of family history of coronary artery disease in young individuals (from the CONFIRM registry). Am J Cardiol. 2013; 111(8):1081-6. DOI: 10.1016/j.amjcard.2012.12.042. View

Elashoff M, Wingrove J, Beineke P, Daniels S, Tingley W, Rosenberg S . Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. BMC Med Genomics. 2011; 4:26. PMC: 3072303. DOI: 10.1186/1755-8794-4-26. View

Desta L, Jernberg T, Spaak J, Hofman-Bang C, Persson H . Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91,360 patients admitted with index myocardial infarction between 1998 and 2010. Eur J Heart Fail. 2015; 18(1):46-53. DOI: 10.1002/ejhf.416. View

Pekkanen J, Linn S, Heiss G, Suchindran C, Leon A, Rifkind B . Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med. 1990; 322(24):1700-7. DOI: 10.1056/NEJM199006143222403. View

Shah P . Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion. Prog Cardiovasc Dis. 2002; 44(5):357-68. DOI: 10.1053/pcad.2002.123473. View

Montalescot G, Sechtem U, Andreotti F, Arden C, Budaj A, Bugiardini R . 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013; 34(38):2949-3003. DOI: 10.1093/eurheartj/eht296. View

Libby P, Ridker P, Hansson G . Progress and challenges in translating the biology of atherosclerosis. Nature. 2011; 473(7347):317-25. DOI: 10.1038/nature10146. View

10.

Frey P, Waters D, DeMicco D, Breazna A, Samuels L, Pipe A . Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials). Am J Cardiol. 2010; 107(2):145-50. DOI: 10.1016/j.amjcard.2010.09.006. View

11.

Chhatriwalla A, Nicholls S, Wang T, Wolski K, Sipahi I, Crowe T . Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis. J Am Coll Cardiol. 2009; 53(13):1110-5. DOI: 10.1016/j.jacc.2008.09.065. View

12.

Kraus W . Genetic approaches for the investigation of genes associated with coronary heart disease. Am Heart J. 2000; 140(4):S27-35. DOI: 10.1067/mhj.2000.109380. View

13.

Bayturan O, Kapadia S, Nicholls S, Tuzcu E, Shao M, Uno K . Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol. J Am Coll Cardiol. 2010; 55(24):2736-42. DOI: 10.1016/j.jacc.2010.01.050. View

14.

Khot U, Khot M, Bajzer C, Sapp S, Ohman E, Brener S . Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003; 290(7):898-904. DOI: 10.1001/jama.290.7.898. View

15.

Caudell E, Caudell J, Tang C, Yu T, Frederick M, Grimm E . Characterization of human copine III as a phosphoprotein with associated kinase activity. Biochemistry. 2000; 39(42):13034-43. DOI: 10.1021/bi001250v. View

16.

Lin H, Zhang F, Geng Q, Yu T, Cui Y, Liu X . Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC. J Proteome Res. 2013; 12(7):3423-33. DOI: 10.1021/pr400273z. View

17.

Aziz H, Zaas A, Ginsburg G . Peripheral blood gene expression profiling for cardiovascular disease assessment. Genomic Med. 2008; 1(3-4):105-12. PMC: 2269039. DOI: 10.1007/s11568-008-9017-x. View

18.

Perestenko P, Pooler A, Noorbakhshnia M, Gray A, Bauccio C, McIlhinney R . Copines-1, -2, -3, -6 and -7 show different calcium-dependent intracellular membrane translocation and targeting. FEBS J. 2010; 277(24):5174-89. DOI: 10.1111/j.1742-4658.2010.07935.x. View

19.

Bayturan O, Tuzcu E, Uno K, Lavoie A, Hu T, Shreevatsa A . Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome. Am J Cardiol. 2010; 105(12):1735-9. DOI: 10.1016/j.amjcard.2010.01.359. View

20.

Kronmal R, McClelland R, Detrano R, Shea S, Lima J, Cushman M . Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2007; 115(21):2722-30. DOI: 10.1161/CIRCULATIONAHA.106.674143. View